
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Department of Anatomic Pathology, Pontificia Universidad Catolica de Chile, and Services of 2 Surgery and 3 Anatomic Pathology, Hospital Dr. Sotero del Rio, Santiago, Chile
Purpose: Mutations in the mitochondrial DNA (mtDNA) have been observed frequently in human neoplasia, in both coding and noncoding regions. A mononucleotide repeat (poly-C) between 303 and 315 nucleotides (D310) within the regulatory displacement loop has been identified recently as a frequent hot spot of deletion/insertion mutations in tumors. We investigated the frequency and pattern of D310 abnormalities in the pathogenesis of gallbladder carcinoma (GBC).
Experimental Design: DNA extracted from neoplastic and nonneoplastic archival gallbladder tissue including 123 tumors, 53 dysplastic areas, and 90 histologically normal epithelia adjacent to GBC, chronic cholecystitis, and 15 normal gallbladders were examined by PCR-based assay for D310 mutations, followed by sequencing in a subset of cases.
Results: D310 mutation was a relatively frequent (47 of 123; 38%) abnormality in GBC. A very high frequency of mutations were detected in dysplastic (8 of 14; 57%) and normal-appearing gallbladder epithelia (10 of 22; 46%) accompanying GBC, showing a clonal relationship compared with the corresponding tumors. D310 mutations were also detected in dysplastic (8 of 39; 21%) and normal (17 of 68; 25%) epithelia obtained from chronic cholecystitis. A single case of 15 normal gallbladders showed a D310 abnormality. Overall, deletions (67 of 91; 74%) at D310 were more frequent than insertions.
Conclusions: D310 mutation at the mtDNA displacement loop is a relatively frequent and early event in the sequential pathogenesis of GBC, being detected in normal-appearing epithelium from chronic cholecystitis. Our findings suggest that mtDNA mutations should be additionally investigated in GBC pathogenesis, and D310 mononucleotide abnormalities could be included in a panel of molecular biomarkers for GBC early detection strategy.
This article has been cited by other articles:
![]() |
H.-W. Park, Y. Ahn, M.-H. Jeong, J.-G. Cho, J.-C. Park, J.-C. Kang, M.-G. Shin, J.-H. Shin, S.-P. Suh, D.-W. Ryang, et al. Chronic atrial fibrillation associated with somatic mitochondrial DNA mutations in human atrial tissue J. Clin. Pathol., August 1, 2007; 60(8): 948 - 950. [Full Text] [PDF] |
||||
![]() |
S.L. Prior, A.P. Griffiths, J.M. Baxter, P.W. Baxter, S.C. Hodder, K.C. Silvester, and P.D. Lewis Mitochondrial DNA mutations in oral squamous cell carcinoma Carcinogenesis, May 1, 2006; 27(5): 945 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. WANG, V. W.S. LIU, H. Y.S. NGAN, and P. NAGLEY Frequent Occurrence of Mitochondrial Microsatellite Instability in the D-Loop Region of Human Cancers Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 123 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi, N. Shivapurkar, E. Riquelme, H. Shigematsu, J. Reddy, M. Suzuki, K. Miyajima, X. Zhou, B. N. Bekele, A. F. Gazdar, et al. Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis Clin. Cancer Res., September 15, 2004; 10(18): 6126 - 6133. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |